• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

VIP Gene Record

  • Summary
  • Interactions
  • Claims
  • VIP 7432 Druggable Genome

    Alternate Names:

    7432
    VASOACTIVE INTESTINAL PEPTIDE
    VIP
    PHM27
    192320
    12693
    ENSG00000146469
    OTTHUMG00000015851

    Gene Info:

    Gene Biotype PROTEIN_CODING
    (0 More Sources)

    Gene Categories: Category Details

    HORMONE ACTIVITY
    DRUGGABLE GENOME

    Publications:

    Fouchier et al., The effects of ribavirin on the GTP level and the VIP receptor dynamic of human IGR39 cells., J. Recept. Signal Transduct. Res.
    Tang et al., 1995, Gut peptide receptors in pancreata of azaserine-treated and normal control rats., Carcinogenesis
    Woie et al., 1987, Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes., Gen. Pharmacol.
    Shen et al., 2000, Effects of androgen and ageing on gene expression of vasoactive intestinal polypeptide in rat corpus cavernosum., BJU Int.
    Katagiri et al., 2005, Omeprazole raises somatostatin and motilin in human plasma., Biol. Pharm. Bull.
    Montalvo et al., 2000, Effect of flutamide-induced androgen-receptor blockade on adenylate cyclase activation through G-protein coupled receptors in rat prostate., Cell. Signal.
    Maigaard et al., Digoxin inhibition of relaxation induced by prostacyclin and vasoactive intestinal polypeptide in small human placental arteries., Placenta
  • AZASERINE   VIP

    Interaction Score: 3.53

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    8603469


    Sources:
    NCI

  • LISINOPRIL   VIP

    Interaction Score: 2.52

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    2822521


    Sources:
    NCI

  • FLUTAMIDE   VIP

    Interaction Score: 0.93

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    10822172


    Sources:
    NCI

  • ANDROSTANOLONE   VIP

    Interaction Score: 0.77

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    10886097


    Sources:
    NCI

  • RIBAVIRIN   VIP

    Interaction Score: 0.55

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    8771530


    Sources:
    NCI

  • OMEPRAZOLE   VIP

    Interaction Score: 0.54

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    15684503


    Sources:
    NCI

  • DIGOXIN   VIP

    Interaction Score: 0.52

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    3906626


    Sources:
    NCI

  • Ensembl: ENSG00000146469

    • Version: 101_38

    Alternate Names:
    VIP Ensembl Gene Name

    Gene Info:
    Gene Biotype PROTEIN_CODING

    Publications:

  • NCI: VIP

    • Version: 14-September-2017

    Alternate Names:

    Gene Info:

    Publications:
    Fouchier et al., The effects of ribavirin on the GTP level and the VIP receptor dynamic of human IGR39 cells., J. Recept. Signal Transduct. Res.
    Maigaard et al., Digoxin inhibition of relaxation induced by prostacyclin and vasoactive intestinal polypeptide in small human placental arteries., Placenta
    Shimozato et al., 1997, Indirect suppression of IL-7-responsive B cell precursors by vasoactive intestinal peptide., J. Immunol.

  • HingoraniCasas: ENSG00000146469

    • Version: 31-May-2017

    Alternate Names:
    ENSG00000146469 Gene Symbol
    VIP Ensembl Id

    Gene Info:

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

  • GO: VIP

    • Version: 01-February-2022

    Alternate Names:

    Gene Info:

    Gene Categories:
    HORMONE ACTIVITY

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21